In the Apoe knock-out mice, diabetes induction by streptozotocin (STZ) for 20 weeks resulted in dyslipidemia, elevated pro-inflammatory and pro-sclerotic markers, and 5-fold larger aortic atherosclerotic plaque areas compared to the control [162]. This evidence concerns the gene APOE and metabolic syndrome.